Home > Boards > US OTC > Delisted > BioAmber Inc. (fka BIOAQ)

To be clear...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
kevroc Member Profile
Member Level 
Followed By 27
Posts 733
Boards Moderated 1
Alias Born 06/07/18
160x600 placeholder
kevroc Member Level  Monday, 10/21/19 01:19:38 PM
Re: Pi_Sky2017 post# 86552
Post # of 91893 
To be clear...
I have no idea what will happen here. My previous post was simply a guess based on limited facts. It's possible Sorhay has Canadian connections that were party to the lawsuit and they may have received distributions from that settlement.

The $5.55 weighted average was calculated at the time when Bioamber and it's subs were intact. That is no longer the case. Bioamber, Inc. sold it's most valuable asset: Bioamber Sarnia, Inc. Therefore, the valuation for Bioamber, Inc is much lower than it was prior to May 8, 2018.

I absolutely do not believe BIOAQ common shares will fetch anywhere near $5.55 at the conclusion of this process. That is why a feel relatively safe knowing that I will not be sh*tting a brick anytime soon.

IF there is a tender offer... it will definitely be based on the current valuation of the remaining business of Bioamber, Inc. and will have absolutely no connection to Visolis/LCY NOR the planned usage of the plant they bought OCT 2018. Question is... how much is IP, NOLs and billion dollar contracts worth to the buyer? One thing to watch is what happens to the Vinmar contracts before DEC 31... do they expire, or do they get extended??? Won't that be exciting? smile

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist